Aimee J. Lenar
Equibles does not estimate personal net worth.
Get an email with a short summary when Bausch Health Companies Inc. publishes a filing, an earnings call transcript or a press release.
Get BHC alertsAbout Aimee J. Lenar
The proxy statement of Bausch Health Companies Inc. reports total compensation of $3,264,491 for Aimee J. Lenar in fiscal 2025, including a base salary of $650,000. Disclosed compensation is on record for 2 fiscal years. Bausch Health Companies Inc. is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Other leadership on record at Bausch Health Companies Inc. includes Joseph Papa (CEO), Thomas Appio (CEO), Thomas J. Appio (CEO and Board Member) and 7 others.
Affiliation history
-
Bausch Health Companies Inc. (BHC)
Proxy statement
CurrentStart not stated–present
Last confirmed April 8, 2026
Company network
Leadership on record at Bausch Health Companies Inc.
- Joseph Papa CEO
- Thomas Appio CEO
- Thomas J. Appio CEO, Board Member
- John A. Paulson Chairman, Board Member
- Jean-Jacques Charhon CFO
- Jean-Jaques Charhon CFO
- John Barresi CFO
- Paul Herendeen CFO
- Seana Carson General Counsel
- John S. Barresi Chief Accounting Officer
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Bausch Health Companies Inc. (BHC) | Executive Vice President, US Pharma | $650,000 | $3,264,491 |
| 2024 | Bausch Health Companies Inc. (BHC) | Executive Vice President, US Pharma | $300,000 | $1,986,437 |
Recent activity
No call appearances or filed executive changes recorded yet.